SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-054562
Filing Date
2019-10-30
Accepted
2019-10-30 20:01:30
Documents
1
Period of Report
2019-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1491
  Complete submission text file 0001209191-19-054562.txt   2863
Mailing Address 5425 WISCONSIN AVE CHEVY CHASE MD 20815
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39112 | Film No.: 191181614

Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Issuer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)